Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Mutations in TBR1 gene leads to cortical malformations and intellectual disability.

Vegas N, Cavallin M, Kleefstra T, de Boer L, Philbert M, Maillard C, Boddaert N, Munnich A, Hubert L, Bery A, Besmond C, Bahi-Buisson N.

Eur J Med Genet. 2018 Sep 27. pii: S1769-7212(17)30791-7. doi: 10.1016/j.ejmg.2018.09.012. [Epub ahead of print]

PMID:
30268909
2.

Recurrent RTTN mutation leading to severe microcephaly, polymicrogyria and growth restriction.

Cavallin M, Bery A, Maillard C, Salomon LJ, Bole C, Reilly ML, Nitschké P, Boddaert N, Bahi-Buisson N.

Eur J Med Genet. 2018 Aug 16. pii: S1769-7212(17)30720-6. doi: 10.1016/j.ejmg.2018.08.001. [Epub ahead of print]

PMID:
30121372
3.

TLE1, a key player in neurogenesis, a new candidate gene for autosomal recessive postnatal microcephaly.

Cavallin M, Maillard C, Hully M, Philbert M, Boddaert N, Reilly ML, Nitschké P, Bery A, Bahi-Buisson N.

Eur J Med Genet. 2018 May 25. pii: S1769-7212(17)30773-5. doi: 10.1016/j.ejmg.2018.05.002. [Epub ahead of print]

PMID:
29758293
4.

WDR81 mutations cause extreme microcephaly and impair mitotic progression in human fibroblasts and Drosophila neural stem cells.

Cavallin M, Rujano MA, Bednarek N, Medina-Cano D, Bernabe Gelot A, Drunat S, Maillard C, Garfa-Traore M, Bole C, Nitschké P, Beneteau C, Besnard T, Cogné B, Eveillard M, Kuster A, Poirier K, Verloes A, Martinovic J, Bidat L, Rio M, Lyonnet S, Reilly ML, Boddaert N, Jenneson-Liver M, Motte J, Doco-Fenzy M, Chelly J, Attie-Bitach T, Simons M, Cantagrel V, Passemard S, Baffet A, Thomas S, Bahi-Buisson N.

Brain. 2017 Oct 1;140(10):2597-2609. doi: 10.1093/brain/awx218.

PMID:
28969387
5.

Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control.

Apter D, Zimmerman Y, Beekman L, Mawet M, Maillard C, Foidart JM, Coelingh Bennink HJT.

Eur J Contracept Reprod Health Care. 2017 Aug;22(4):260-267. doi: 10.1080/13625187.2017.1336532. Epub 2017 Jun 22.

PMID:
28641030
6.

Neuropathological Hallmarks of Brain Malformations in Extreme Phenotypes Related to DYNC1H1 Mutations.

Laquerriere A, Maillard C, Cavallin M, Chapon F, Marguet F, Molin A, Sigaudy S, Blouet M, Benoist G, Fernandez C, Poirier K, Chelly J, Thomas S, Bahi-Buisson N.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):195-205. doi: 10.1093/jnen/nlw124.

PMID:
28395088
7.

Prenatal and postnatal presentations of corpus callosum agenesis with polymicrogyria caused by EGP5 mutation.

Maillard C, Cavallin M, Piquand K, Philbert M, Bault JP, Millischer AE, Moshous D, Rio M, Gitiaux C, Boddaert N, Masson C, Thomas S, Bahi-Buisson N.

Am J Med Genet A. 2017 Mar;173(3):706-711. doi: 10.1002/ajmg.a.38061. Epub 2017 Feb 7.

PMID:
28168853
8.

Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.

Bastos DC, Paupert J, Maillard C, Seguin F, Carvalho MA, Agostini M, Coletta RD, Noël A, Graner E.

Lab Invest. 2017 Feb;97(2):194-206. doi: 10.1038/labinvest.2016.125. Epub 2016 Dec 5.

9.

A novel recurrent LIS1 splice site mutation in classic lissencephaly.

Philbert M, Maillard C, Cavallin M, Goldenberg A, Masson C, Boddaert N, El Morjani A, Steffann J, Chelly J, Gerard X, Bahi-Buisson N.

Am J Med Genet A. 2017 Feb;173(2):561-564. doi: 10.1002/ajmg.a.38041. Epub 2016 Nov 27. No abstract available.

PMID:
27891766
10.

Recurrent KIF2A mutations are responsible for classic lissencephaly.

Cavallin M, Bijlsma EK, El Morjani A, Moutton S, Peeters EA, Maillard C, Pedespan JM, Guerrot AM, Drouin-Garaud V, Coubes C, Genevieve D, Bole-Feysot C, Fourrage C, Steffann J, Bahi-Buisson N.

Neurogenetics. 2017 Apr;18(2):73-79. doi: 10.1007/s10048-016-0499-8. Epub 2016 Oct 17.

PMID:
27747449
11.

Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).

Apter D, Zimmerman Y, Beekman L, Mawet M, Maillard C, Foidart JM, Coelingh Bennink HJ.

Contraception. 2016 Oct;94(4):366-73. doi: 10.1016/j.contraception.2016.04.015. Epub 2016 May 3.

12.

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.

Duijkers IJ, Klipping C, Zimmerman Y, Appels N, Jost M, Maillard C, Mawet M, Foidart JM, Coelingh Bennink HJ.

Eur J Contracept Reprod Health Care. 2015;20(6):476-89. doi: 10.3109/13625187.2015.1074675.

13.

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.

Mawet M, Maillard C, Klipping C, Zimmerman Y, Foidart JM, Coelingh Bennink HJ.

Eur J Contracept Reprod Health Care. 2015;20(6):463-75. doi: 10.3109/13625187.2015.1068934. Epub 2015 Jul 27.

14.

[Opening the window].

Maillard C, Salles N.

Krankenpfl Soins Infirm. 2015;108(6):75. French. No abstract available.

PMID:
26148420
15.

Detecting nanoscale vibrations as signature of life.

Kasas S, Ruggeri FS, Benadiba C, Maillard C, Stupar P, Tournu H, Dietler G, Longo G.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):378-81. doi: 10.1073/pnas.1415348112. Epub 2014 Dec 29.

16.

Altered α-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour-permissive microenvironment.

Hubert P, Herman L, Roncarati P, Maillard C, Renoux V, Demoulin S, Erpicum C, Foidart JM, Boniver J, Noël A, Delvenne P, Herfs M.

J Pathol. 2014 Dec;234(4):464-77. doi: 10.1002/path.4435. Epub 2014 Oct 6.

PMID:
25196670
17.

Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study.

Baffert S, Cottu P, Kirova YM, Mercier F, Simondi C, Bachelot T, Le Rhun E, Levy C, Gutierrez M, Madranges N, Moldovan C, Coudert B, Spaëth D, Serin D, Cotté FE, Benjamin L, Maillard C, Laulhere-Vigneau S, Durand-Zaleski I.

BMC Health Serv Res. 2013 Oct 31;13:456. doi: 10.1186/1472-6963-13-456.

18.

Histology of the vaginal wall in women with pelvic organ prolapse: a literature review.

De Landsheere L, Munaut C, Nusgens B, Maillard C, Rubod C, Nisolle M, Cosson M, Foidart JM.

Int Urogynecol J. 2013 Dec;24(12):2011-20. doi: 10.1007/s00192-013-2111-1. Epub 2013 May 7. Review.

19.

Sunitinib inhibits inflammatory corneal lymphangiogenesis.

Detry B, Blacher S, Erpicum C, Paupert J, Maertens L, Maillard C, Munaut C, Sounni NE, Lambert V, Foidart JM, Rakic JM, Cataldo D, Noël A.

Invest Ophthalmol Vis Sci. 2013 May 3;54(5):3082-93. doi: 10.1167/iovs.12-10856.

20.

Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase.

Detry B, Erpicum C, Paupert J, Blacher S, Maillard C, Bruyère F, Pendeville H, Remacle T, Lambert V, Balsat C, Ormenese S, Lamaye F, Janssens E, Moons L, Cataldo D, Kridelka F, Carmeliet P, Thiry M, Foidart JM, Struman I, Noël A.

Blood. 2012 May 24;119(21):5048-56. doi: 10.1182/blood-2011-12-400267. Epub 2012 Apr 6.

21.

The angiostatic protein 16K human prolactin significantly prevents tumor-induced lymphangiogenesis by affecting lymphatic endothelial cells.

Kinet V, Castermans K, Herkenne S, Maillard C, Blacher S, Lion M, Noël A, Martial JA, Struman I.

Endocrinology. 2011 Nov;152(11):4062-71. doi: 10.1210/en.2011-1081. Epub 2011 Aug 23.

PMID:
21862622
22.

Digging deeper into lymphatic vessel formation in vitro and in vivo.

Detry B, Bruyère F, Erpicum C, Paupert J, Lamaye F, Maillard C, Lenoir B, Foidart JM, Thiry M, Noël A.

BMC Cell Biol. 2011 Jun 24;12:29. doi: 10.1186/1471-2121-12-29.

23.

Does plasminogen activator inhibitor-1 drive lymphangiogenesis?

Bruyère F, Melen-Lamalle L, Blacher S, Detry B, Masset A, Lecomte J, Lambert V, Maillard C, Høyer-Hansen G, Lund LR, Foidart JM, Noël A.

PLoS One. 2010 Mar 11;5(3):e9653. doi: 10.1371/journal.pone.0009653.

24.

Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Masset A, Maillard C, Sounni NE, Jacobs N, Bruyére F, Delvenne P, Tacke M, Reinheckel T, Foidart JM, Coussens LM, Noël A.

Int J Cancer. 2011 Jan 15;128(2):283-93. doi: 10.1002/ijc.25326. Epub 2010 Mar 15.

25.

Higher sensitivity of Adamts12-deficient mice to tumor growth and angiogenesis.

El Hour M, Moncada-Pazos A, Blacher S, Masset A, Cal S, Berndt S, Detilleux J, Host L, Obaya AJ, Maillard C, Foidart JM, Ectors F, Noel A, Lopez-Otin C.

Oncogene. 2010 May 20;29(20):3025-32. doi: 10.1038/onc.2010.49. Epub 2010 Mar 8.

26.

Unusual skeletal muscle metastasis from gastric adenocarcinoma.

Tougeron D, Hamidou H, Dujardin F, Maillard C, Di Fiore F, Michel P.

Gastroenterol Clin Biol. 2009 Jun-Jul;33(6-7):485-7. doi: 10.1016/j.gcb.2009.03.018. Epub 2009 May 27.

27.

Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis.

Bajou K, Peng H, Laug WE, Maillard C, Noel A, Foidart JM, Martial JA, DeClerck YA.

Cancer Cell. 2008 Oct 7;14(4):324-34. doi: 10.1016/j.ccr.2008.08.012.

28.

Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors.

Maillard CM, Bouquet C, Petitjean MM, Mestdagt M, Frau E, Jost M, Masset AM, Opolon PH, Beermann F, Abitbol MM, Foidart JM, Perricaudet MJ, Noël AC.

Carcinogenesis. 2008 Nov;29(11):2236-42. doi: 10.1093/carcin/bgn204. Epub 2008 Aug 27.

29.

Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.

Almeida S, Maillard C, Itin P, Hohl D, Huber M.

J Invest Dermatol. 2008 Mar;128(3):587-93. Epub 2007 Sep 13.

30.

Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.

Jost M, Maillard C, Lecomte J, Lambert V, Tjwa M, Blaise P, Alvarez Gonzalez ML, Bajou K, Blacher S, Motte P, Humblet C, Defresne MP, Thiry M, Frankenne F, Gothot A, Carmeliet P, Rakic JM, Foidart JM, Noël A.

Am J Pathol. 2007 Oct;171(4):1369-80. Epub 2007 Aug 23.

31.

Defensins induce the recruitment of dendritic cells in cervical human papillomavirus-associated (pre)neoplastic lesions formed in vitro and transplanted in vivo.

Hubert P, Herman L, Maillard C, Caberg JH, Nikkels A, Pierard G, Foidart JM, Noel A, Boniver J, Delvenne P.

FASEB J. 2007 Sep;21(11):2765-75. Epub 2007 Apr 30.

PMID:
17470569
32.

Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.

Bougouin C, Thelcide C, Crespin-Maillard F, Maillard C, Kinowski JM, Favier M.

Am J Health Syst Pharm. 2005 Oct 1;62(19):2001-5.

PMID:
16174836
33.

Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner.

Maillard C, Jost M, Rømer MU, Brunner N, Houard X, Lejeune A, Munaut C, Bajou K, Melen L, Dano K, Carmeliet P, Fusenig NE, Foidart JM, Noel A.

Neoplasia. 2005 Jan;7(1):57-66.

34.

[Will there be microbes in airplanes?].

Maillard C.

Servir. 2004 Nov-Dec;52(6):310. Portuguese. No abstract available.

PMID:
15682712
35.

Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes.

Masson V, de la Ballina LR, Munaut C, Wielockx B, Jost M, Maillard C, Blacher S, Bajou K, Itoh T, Itohara S, Werb Z, Libert C, Foidart JM, Noël A.

FASEB J. 2005 Feb;19(2):234-6. Epub 2004 Nov 18.

36.

Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions.

Hubert P, Evrard B, Maillard C, Franzen-Detrooz E, Delattre L, Foidart JM, Noël A, Boniver J, Delvenne P.

Antimicrob Agents Chemother. 2004 Nov;48(11):4342-8.

37.

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth.

Bajou K, Maillard C, Jost M, Lijnen RH, Gils A, Declerck P, Carmeliet P, Foidart JM, Noel A.

Oncogene. 2004 Sep 9;23(41):6986-90.

38.

Membrane associated proteases and their inhibitors in tumour angiogenesis.

Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM.

J Clin Pathol. 2004 Jun;57(6):577-84. Review.

39.

Role of plasminogen activator-plasmin system in tumor angiogenesis.

Rakic JM, Maillard C, Jost M, Bajou K, Masson V, Devy L, Lambert V, Foidart JM, Noël A.

Cell Mol Life Sci. 2003 Mar;60(3):463-73. Review.

40.

[Glucides in the nutrition of obese patients].

Maillard C.

Servir. 2002 Sep-Oct;50(5):247-9. Portuguese. No abstract available.

PMID:
12494530
41.

[Glucides in the nutrition of diabetics].

Maillard C.

Servir. 2002 Sep-Oct;50(5):244-6. Portuguese. No abstract available.

PMID:
12494529
42.

[Diseases and nutrition: a primordial challenge in Public Health].

Maillard C.

Servir. 2002 Sep-Oct;50(5):241-3. Portuguese. No abstract available.

PMID:
12494528
43.

[Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and prothrombin mutations].

Leret N, Cortey A, Maillard C, Rouabah M, Hascoët JM, Lecompte T, de Maistre E.

Arch Pediatr. 2001 Nov;8(11):1222-5. French.

PMID:
11760675
44.

QT interval lengthening in premature infants treated with doxapram.

Maillard C, Boutroy MJ, Fresson J, Barbé F, Hascoët JM.

Clin Pharmacol Ther. 2001 Dec;70(6):540-5.

PMID:
11753270
45.

Acquired uterine arteriovenous fistulas after choriocarcinoma. A case report.

Delaloye JF, Maillard C, Laurini R, Hack I, De Grandi P.

Eur J Gynaecol Oncol. 1998;19(5):453-4. No abstract available.

PMID:
9863910
46.

An analytical study, anti-inflammatory and analgesic effects of Harpagophytum procumbens and Harpagophytum zeyheri.

Baghdikian B, Lanhers MC, Fleurentin J, Ollivier E, Maillard C, Balansard G, Mortier F.

Planta Med. 1997 Apr;63(2):171-6.

PMID:
9140234
47.

[The freedom of hospitals in history].

Maillard C.

Bull Soc Fr Hist Hop. 1995;(80):35-9. French. No abstract available.

PMID:
11625881
48.

[Relationship between perceived health status and career choice in a sample of wage-earners].

Derriennic F, Maillard C, Fassina N, Fortier-Launois M, Lamarre G, Le Chevanton N, Monfort C, Neel B, Pasquier C, Rabusson-Corvisart D, et al.

Rev Epidemiol Sante Publique. 1995;43(3):259-71. French.

PMID:
7784675
49.

[Prenatal diagnosis of genetic diseases: Lausanne experience 1989-1993].

Fokstuen S, Pescia G, Addor MC, Gaide AC, Marguerat P, Maillard C, Vial Y, Hohlfeld P, Nguyen The H.

Rev Med Suisse Romande. 1994 Dec;114(12):1055-65. Review. French. No abstract available.

PMID:
7817068
50.

Thrombomodulin is synthesized by osteoblasts, stimulated by 1,25-(OH)2D3 and activates protein C at their cell membrane.

Maillard C, Berruyer M, Serre CM, Amiral J, Dechavanne M, Delmas PD.

Endocrinology. 1993 Aug;133(2):668-74.

PMID:
8393772

Supplemental Content

Loading ...
Support Center